fda warning unapproved peptides bpc-157 tb-500 cjc-1295 ipamorelin fda banning semaglutide FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly The Truth About Peptides, Compounding

Schedule a consultation at New Beauty Medical Aesthetics today

Thus far, there is one thing that is clear: the current reference range is set as too low a level, and it may be raised to, conservatively, 500 pmol/L like they have in Japan

The FDA approved semaglutide for type 2 diabetes and weight loss in people with obesity or overweight with at least one weight-related health condition

Enthusiasm in the biohacking community far outruns the published data

Individuals Experiencing Metabolic Slowdown People noticing reduced metabolic efficiency due to aging or lifestyle factors may consider 5-Amino-1MQ under medical supervision

Companies selling research peptides walk a careful line